Delivery Order SPE2DB25D3201-SPE2DB25FNVRE
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $39,673.94 delivery order to AmerisourceBergen Drug Corp for the supply of Ruxience 500 mg/50 ml vials on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ruxience 500 mg/50 mL vials, a biosimilar medication used in cancer treatment. This firm fixed-price delivery order, valued at $7,421.74, represents a non-set-aside competitive award with an ultimate completion date of August 13, 2025. The pharmaceutical products will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ruxience 500 mg/50 mL vials with a contract value of $2,935.32 and a completion date of August 5, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed-price pricing and represents a pharmaceutical supply transaction under the company's existing Indefinite Delivery Contract relationship with DLA. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ruxience 100 mg/10 mL vials valued at $1,956.80 under a firm fixed-price contract. This delivery order represents a non-set-aside competitive award and is part of a larger indefinite delivery contract (IDC) vehicle designated SPE2DX with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed and delivered...
- Amerisourcebergen Drug Corp has received a $4,135.64 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply Ruxience 500 MG/50 ML vials. As the prime contractor, Amerisourcebergen will deliver 50 mL vials of the specified pharmaceutical product to the place of performance in Conshohocken, Pennsylvania by the October 26, 2023 completion date. No set-aside designation was applied to this award issued against an indefinite delivery contract held by...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,796.78 order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,550.87, is a delivery order for the pharmaceutical product Ruxience 500 mg/50 ml vial with an ultimate completion date of May 8, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $25,827.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug RUXIENCE 500 MG/50 ML VIAL 50ML. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 500 mg/50 ml vials of the pharmaceutical product RUXIENCE. The $5,674.50 order has a completion date of December 22, 2023 and was awarded on December 21, 2023. As a prime contractor to DLA, Amerisourcebergen has supplied a range of pharmaceutical and medical products to support military treatment programs and facilities. This...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,080.62 firm fixed-price delivery order is for the supply of 500 mg/50 ml vials of the drug RUXIENCE. The contract has an ultimate completion date of January 10, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...